On 28 May, a MORU Malaria Research team arrived in Chittagong, Bangladesh, where, for the next few months, they will conduct studies on the pathophysiology and treatment of severe malaria.at the Chittagong Medical College Hospital.
Arjen Dondorp, Malaria Department Head and Deputy Director, leads the team. MORU has conducted research in Chittagong for the past 12 years. This year, for the first time, two MORU research doctors will also work on severe malaria in Ramu, one of the TRAC sites.
In Bangladesh, MORU onducts treatment studies in severe and uncomplicated malaria, investigates the ever-increasing problem of antimalarial drug resistance, and uses innovative tools to investigate the complicated pathophysiology of malaria.
MORU researchers work with Bangladeshi colleagues in the Chittagong Medical College Hospital, a large 1,000-bed hospital – with an intensive care unit that MORU helped develop a few years ago by providing courses in critical care management.
Although conditions in Bangladesh are not always easy, many important studies have been completed in Chittagong. SEAQUAMAT was an early one, with another 25 publications since then, and quite a few more in preparation.
Other prior MORU research work in Chittagong includes a typhoid and fever study by the MORU Microbiology Department, and a TB study with the Academic Medical Centre in Amsterdam.
All this would not have been possible without strong local support, including Prof. Abul Faiz, who began the collaboration, Prof. Mahtab, Prof. Amir, Prof. Emran, Dr. Joy, microscopists Sanjib and Shumon, and of course Safiq, who always takes care of everything.